ND-0901

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameND-0901
Drug Alias NameND-0901
ClassificationSmall molecules
Mechanisms of ActionDopamine receptors agonistsDOPA decarboxylase inhibitors
TargetsDopamine receptorsAromatic-L-amino-acid decarboxylase
Therapy Area/IndicationsParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNeuroderm Ltd
China Registration ClassN/A

Develop Information

Active CompaniesNeuroderm Ltd
Inactive CompaniesN/A
Active IndicationsParkinson Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A